Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Th. Kaltsas"'
Publikováno v:
The Endocrinologist. 13:7-11
Cushing disease accounts for 80% to 85% of ACTH-dependent disease, whereas 15% to 20% is caused by ectopic sources. Cyclical Cushing syndrome is an unusual phenomenon and is frequently associated with a pituitary adenoma. Diagnostic and therapeutic p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1884ee08131e03eb02cd869027ca5835
https://doi.org/10.1097/00019616-200301000-00003
https://doi.org/10.1097/00019616-200301000-00003
Autor:
Jane Paunkovic, G. E. Krassas, Ph. Papadopoulou, Th. Kaltsas, Nebojsa Paunkovic, N. Pontikides, Leonidas H. Duntas
Publikováno v:
Clinical Endocrinology. 50:655-659
OBJECTIVES Most thyroid textbooks describe hypo-thyroidism resulting in changes in the length of the menstrual cycle and in the amount of bleeding. Our experience at a busy thyroid clinic had given a picture which differs from that presented in the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c875ea1eb9ebd017115a7760576f7f2
https://doi.org/10.1046/j.1365-2265.1999.00719.x
https://doi.org/10.1046/j.1365-2265.1999.00719.x
Autor:
Th. Kaltsas, N. Pontikides, Dimitrios Lolis, K. Seferiadis, Gerasimos E Krassas, Ioannis E. Messinis
Publikováno v:
Human Reproduction. 13:22-26
The suppression of the pituitary-gonadal axis by the administration of gonadotrophin-releasing hormone agonists (GnRH-a) is used occasionally as an adjunct therapy with gonadotrophins for ovulation induction in women with polycystic ovarian syndrome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d80fffc08485b9f144001bad7d1d07ac
https://doi.org/10.1093/humrep/13.1.22
https://doi.org/10.1093/humrep/13.1.22
Publikováno v:
European Journal of Endocrinology. 136:416-422
Octreotide, a potent synthetic somatostatin (SM) analogue, was recently evaluated and found to have a beneficial effect in thyroid eye disease (TED), mostly in those patients with a positive Octreoscan-111. Lanreotide (LRT; Somatuline-Ipsen), a new S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51b5072e4d308cf0743167b4e19e5c27
https://doi.org/10.1530/eje.0.1360416
https://doi.org/10.1530/eje.0.1360416
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 9(1)
Octreotide, a potent synthetic long-acting somatostatin analogue, has been shown to have a beneficial effect in thyroid eye disease (TED). Orbital scintigraphy using ocetreoscan-111 is a useful study, which can be used to visualize somatostatin-recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af790c627281c498e623848844a2ba70
https://pubmed.ncbi.nlm.nih.gov/10037076
https://pubmed.ncbi.nlm.nih.gov/10037076
Autor:
Ioannis E. Messinis, N. Pontikides, Gerasimos E Krassas, Th. Kaltsas, Dimitrios Lolis, K. Seferiadis
Recent clinical studies have suggested that women with polycystic ovarian syndrome (PCOS) may have disturbances of growth hormone (GH) kinetics and the GH/insulin-like growth factor (IGF)-I system. The knowledge that in various metabolic abnormalitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f7da247bd1ddc984cfcd406098f458
http://olympias.lib.uoi.gr/jspui/handle/123456789/21320
http://olympias.lib.uoi.gr/jspui/handle/123456789/21320
Publikováno v:
Clinical endocrinology. 42(6)
OBJECTIVE Octreotide, a potent long-acting synthetic somatostatin analogue, has been reported to have a beneficial effect in thyroid eye disease (TED), but the precise mechanism of action remains unexplained. 111In-DTPA-D-Phe1-octreotide (Octreoscan-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b31872ce3447b4178f6676e5e763438d
https://pubmed.ncbi.nlm.nih.gov/7634496
https://pubmed.ncbi.nlm.nih.gov/7634496
Publikováno v:
Clinical endocrinology. 40(5)
OBJECTIVES In thyroid textbooks it is stated that hyperthyroidism in women may be associated in almost 50% of the cases with hypomenorrhoea, oligomenorrhoea or amenorrhoea and perhaps with reduced fertility. Our experience at a busy thyroid clinic ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a364cf2e4cdd6eab8b068e60a72e2aa
https://pubmed.ncbi.nlm.nih.gov/8013145
https://pubmed.ncbi.nlm.nih.gov/8013145
Publikováno v:
Thyroid. 7:489-489
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34646687947e70cd2bf4edde11f5e34f
https://doi.org/10.1089/thy.1997.7.489
https://doi.org/10.1089/thy.1997.7.489